Abstract
Objective. to determine the general patterns of changes barium sulfat stimulated luminol-dependent chemiluminescence of leukocytes in patients with drug toxidermia caused by taking nurofen (ibuprofen) and in the control group, as well as to select NSAIDs for replacement therapy. Material and methods. the object of the study were 15 patients (11 women and 4 men) with drug toxidemia (7 patients with toxidermia, 4 patients with acute urticaria) developed after taking nurofen (ibuprofen), and a control group consisting of 15 people (9 women and 6 men) who were not intolerant to this drug. The study participants were aged 18 to 75 years, median - 53. Measurement of barium sulfate-stimulated luminol-dependent chemiluminescence (SLCL) of leukocytes was performed on the Lum-100 chemiluminometer. The calculations were carried out using the computer program PowerGraph. Results. during the influence of nurofen (ibuprofen) on the blood of patients with intolerance to this drug and the control group dose-dependent changes in SLCL were observed. The relative intensity and relative light sum of blood SLCL in patients was significantly lower than in the control group at all studied drug concentrations (p < 0.01). SLCL indices in different forms of LT do not differ significantly (p < 0.01). The relative intensity and relative light sum of blood SLCL in patients were significantly lower in samples with the drug that caused the development of the disease than with drugs for replacement therapy (p < 0.01). At minimum concentration, there are no significant differences (p > 0.05).
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call